What cough syrup formulations and dosing regimens should be selected for various patient profiles, such as healthy adults with dry or productive cough, patients with COPD or asthma, elderly individuals, children older than 2 years, and those with gastro‑oesophageal reflux?

Cough Syrup Selection by Patient Profile

For healthy adults with dry cough, use peripheral cough suppressants (levodropropizine, moguisteine) or central agents (codeine 30mg, dextromethorphan 20-30mg) for short-term relief; for productive cough in chronic bronchitis, use central suppressants (codeine, dextromethorphan) or peripheral agents, avoiding mucolytics alone for cough suppression. 1

Healthy Adults

Dry (Non-Productive) Cough

Primary options:

• Peripheral cough suppressants (levodropropizine, moguisteine) are recommended for short-term symptomatic relief in acute/chronic bronchitis 1
• Central suppressants: Codeine 30mg or dextromethorphan 20-30mg reduce cough counts by 40-60% in chronic bronchitis 1
• Cloperastine demonstrates 1.9 times greater efficacy than codeine with onset as early as 20 minutes, without narcotic effects 2

Important caveat: For URI-related dry cough specifically, both peripheral and central suppressants have limited efficacy and are NOT recommended 1. This is a critical distinction—the etiology matters more than cough type.

Combination therapy: For cough with rhinorrhea/congestion, bilastine/dextromethorphan/phenylephrine provides non-sedating relief 3. When non-opioid antitussives fail, codeine 10mg + triprolidine 1.25mg per 5mL (10mL TID for 7 days) significantly reduces severity, frequency, and nighttime awakenings 4.

Productive Cough

• Central suppressants (codeine, dextromethorphan) for symptomatic relief in chronic bronchitis 1
• Hypertonic saline and erdosteine to increase cough clearance on short-term basis 1
• Avoid mucolytics alone—agents altering mucus characteristics are NOT recommended for cough suppression 1

COPD/Asthma Patients

COPD with Cough

• Ipratropium bromide (inhaled) is the ONLY recommended anticholinergic for cough suppression in URI or chronic bronchitis 1
• Central suppressants (codeine 7.5-60mg) reduced cough counts by 60% in COPD patients 1
• Avoid albuterol—not recommended for cough not due to asthma 1

Asthma

• Treat underlying asthma; cough suppressants are adjunctive only
• Albuterol NOT recommended for cough management itself 1

Elderly Individuals

Same principles as adults apply, with dosing considerations:

• Codeine/dextromethorphan combinations remain effective (studies included patients 54-72 years) 1
• Monitor for increased sedation risk with antihistamine combinations
• Real-world data shows similar prescription patterns (62% received antibiotics for productive cough, though often unnecessary) 5

Children (>2 Years)

Critical principle: Base management on etiology, NOT empirical treatment 6

Key Recommendations:

• DO NOT use empirical approach targeting GERD/upper airway cough syndrome/asthma unless specific features present 6
• If empirical trial used, define limited duration to confirm/refute diagnosis 6
• Cloperastine: 6-106mg/day (fendizoate) or 5-400mg/day (hydrochloride), age/weight-adjusted, improves sleep quality and sputum quality 2

What NOT to do:

• Avoid routine additional testing (skin prick, bronchoscopy, chest CT) unless individualized clinical need 6
• Over-the-counter combination cold medications NOT recommended (except older antihistamine-decongestant) 1
• Zinc preparations NOT recommended for common cold 1

Essential intervention:

• Address environmental tobacco smoke exposure—determine and initiate cessation interventions 6

Gastroesophageal Reflux Disease (GERD)

Major pitfall: Empirical anti-reflux treatment is frequently ineffective without proper diagnosis 7

Approach:

• Do NOT empirically treat GERD-related cough unless other GERD features present 6
• Consider vagally-mediated esophageal-bronchial reflex as mechanism 7
• Treat confirmed GERD appropriately, but recognize cough may not improve with reflux treatment alone
• The relationship is bidirectional—lung mechanics can worsen reflux 7

Practical Dosing Algorithm

Duration: 3-7 days for acute cough 4, 5, 8

Adults:

• Codeine: 30mg TID (effective dose; 7.5mg ineffective) 1
• Dextromethorphan: 20-30mg TID 1, 3
• Levodropropizine/moguisteine: per manufacturer guidelines
• Combination (codeine 10mg + triprolidine 1.25mg/5mL): 10mL TID 4

Children:

• Weight/age-adjusted dosing required
• Cloperastine: variable dosing 6-400mg/day depending on formulation and weight 2

Critical Pitfalls to Avoid

1. Don't prescribe cough suppressants for URI-related cough—limited efficacy 1
2. Don't use albuterol for non-asthmatic cough 1
3. Don't empirically treat presumed GERD/rhinosinusitis in children without confirming features 6
4. Don't use mucolytics alone for cough suppression in chronic bronchitis 1
5. Antibiotics are overprescribed—53-62% of cough patients receive them unnecessarily 5